High-Sensitivity C-Reactive Protein and Risk of Sepsis

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Wang, Henry E ^a   Shapiro, Nathan I ^b   Safford, Monika M ^a   Griffin, Russell ^c   Judd, Suzanne ^c   Rodgers, Joel B ^a   Warnock, David G ^a   Cushman, Mary ^d   Howard, George ^c  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COMMUNITY SAMPLE; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HEALTH STATUS; HUMAN; HYPERTENSION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPSIS; UPREGULATION;

AGED; C-REACTIVE PROTEIN; CONFIDENCE INTERVALS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEPSIS;

EID: 84880710090     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069232     Document Type: Article

References (31)

1. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29: 530-538.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
3. Wang HE, Shapiro NI, Angus DC, Yealy DM, (2007) National estimates of severe sepsis in United States emergency departments. Crit Care Med 35: 1928-1936.
4. Martin GS, Mannino DM, Eaton S, Moss M, (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
5. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858-873.
6. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-1377.
7. Ridker PM, (2007) Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev 65: S253-259.
8. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR, (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565.
9. Lloyd-Jones DM, Liu K, Tian L, Greenland P, (2006) Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 145: 35-42.
10. Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R, et al. (1998) C-reactive protein as an indicator of sepsis. Intensive Care Med 24: 1052-1056.
11. Sierra R, Rello J, Bailen MA, Benitez E, Gordillo A, et al. (2004) C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome. Intensive Care Med 30: 2038-2045.
12. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, et al. (2003) C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 123: 2043-2049.
13. Povoa P, Teixeira-Pinto AM, Carneiro AH, (2011) C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Crit Care 15: R169.
14. Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, et al. (2005) C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 11: 101-108.
15. Fraunberger P, Wang Y, Holler E, Parhofer KG, Nagel D, et al. (2006) Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock 26: 10-12.
16. Lee CC, Chen SY, Tsai CL, Wu SC, Chiang WC, et al. (2008) Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock 29: 322-327.
17. Bjerk SM, Baker JV, Emery S, Neuhaus J, Angus B, et al. (2013) Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study. PLoS One 8: e56249.
18. Schmit X, Vincent JL, (2008) The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 36: 213-219.
19. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, et al. (2005) The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology 25: 135-143.
20. Albert MA, Ridker PM, (2006) C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference? Circulation 114: e67-74.
21. (2005) National Institute on Alcohol Abuse and Alcoholism. Helping Patients Who Drink Too Much, a Clinician's Guide.
22. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al (2009) A new equation to estimate glomerular filtration rate. Annals of internal medicine 150: 604-612.
23. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, et al. (2001) Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344: 1959-1965.
24. Bu DX, Griffin G, Lichtman AH, (2011) Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol 22: 165-170.
25. Paffen E, DeMaat MP, (2006) C-reactive protein in atherosclerosis: A causal factor? Cardiovasc Res 71: 30-39.
26. Aird WC, (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101: 3765-3777.
27. Wang HE, Shapiro NI, Griffin R, Safford MM, Judd S, et al. (2013) Inflammatory and endothelial activation biomarkers and risk of sepsis: A nested case-control study. J Crit Care.
28. Yende S, Tuomanen EI, Wunderink R, Kanaya A, Newman AB, et al. (2005) Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia. Am J Respir Crit Care Med 172: 1440-1446.
29. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, et al. (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195-2207.
30. Kumar A (2009) Optimizing antimicrobial therapy in sepsis and septic shock. Crit Care Clin 25: 733-751, viii.
31. Almog Y, Shefer A, Novack V, Maimon N, Barski L, et al. (2004) Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 110: 880-885.